SCOTUS Mixed on Bayer Effort to Corral Roundup Suits: The Brief

SCOTUS Mixed on Bayer Roundup Suit Pitch

Photographer: Graeme Sloan/Bloomberg

Bayer drew a mixed reception from the US Supreme Court on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labeled as a cancer risk. Hearing arguments today, the justices weighed a $1.25 million jury verdict won by a Missouri man who blamed Roundup for his non-Hodgkin lymphoma. The company contends that since US regulators didn’t require a cancer warning, federal law bars the Missouri suit and others like it, Greg Stohr reports.

• Also Read: Bayer Banks on Supreme Court Help to Rein in ...